Sign in
4

Changes in Ownership

Krystal Biotech, Inc. Filed Acc 0001801385-24-000002

Chief Accounting Officer sold 2,500 shares at $130.00 ($325,000)

  • Chief Accounting Officer acquired 2,500 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Romano Kathryn · Chief Accounting Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2024-01-22 Exercise or conversion : show line 1 in the form 10b5-1 +2,500 $52.26 $130,650 15,056 D
2024-01-22 Sale : show line 2 in the form 10b5-1 −2,500 $130.00 $325,000 12,556 D
Open-market sales · 2,500 sh · avg $130.00 · $325,000

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2024-01-22 Exercise or conversion : show line 3 in the form 10b5-1 Stock Option (Right to Buy) −2,500 10,000 D
Loading xslF345X05/wk-form4_1706136270.xml…